Jean-Frederic Colombel

94PUBLICATIONS
286CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCondensed matter characterisation technique development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (94)

|Jul 01, 2026
Engineering immune cell therapies for inflammatory bowel disease: from stem cells to CAR T cells.

|Apr 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.

|Apr 13, 2026
Crohn's disease is an obstructive lymphangitis.

Herbert J Van Kruiningen, Jean-Frederic Colombel, Pietro Tonelli

|Mar 30, 2026
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.

Stefan Schreiber, Bruce E Sands, Silvio Danese

|Mar 18, 2026
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.

Marla C Dubinsky, Stefan Schreiber, Andres J Yarur

|Mar 02, 2026
Screening for preclinical Crohn's disease based on capsule endoscopy is not yet ready.

Brecht Hens, Geert D'Haens, Ryan C Ungaro

Pageof 16

Frequent Collaborators

20 joint publications

Ryan Ungaro

16 joint publications

Manasi Agrawal

11 joint publications

Silvio Danese

9 joint publications

Joana Torres